Locations:
Search IconSearch

Tag: GLP-1 receptor agonists

Dr. Abhay Singh
May 14, 2025/Cancer

Managing Weight and Diabetes May Offer Promise for Blood Cancer Prevention (Podcast)

Use of GLP-1s and improving cardiovascular health lowers risk of hematologic malignancies

Medication Vial
October 14, 2024/Geriatrics/Research

Case Study: Semaglutide Use in Older Patient with Severe Dementia

Complications highlight need to exercise caution when managing geriatric patients

Closeup of physician performing bariatric surgery
October 8, 2024/Digestive/Research

Consider Weight Loss Surgery as a Treatment for Chronic Kidney Disease, Obesity

Findings show greater reduction in CKD progression, kidney failure than GLP-1RAs

Patient holding injectable
May 23, 2024/Digestive/Research

Increased Risk of Gastroparesis Associated with GLP-1RA Use in Type 2 Diabetes Patients

Provider vigilance and patient education are key for management

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

illustration showing action of a GLP-1 receptor agonist

Semaglutide Shows Secondary Cardiovascular Prevention Benefits in Patients Without Diabetes

Findings establish overweight/obesity as a modifiable risk factor for cardiovascular disease

BackPage 2 of 2Next

Advertisement

Ad